BridgeMD
New treatment option for Geographic Atrophy
Official title A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
ClinicalTrials.gov ID: NCT06635148
What this study is testing
What is JNJ-81201887?
JNJ-81201887 is an investigational medicine, given as an injectable medicine, being studied as a potential treatment for geographic atrophy.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The purpose of this study is to assess the long-term safety and tolerability after an intravitreal injection (a shot of medicine into the eye) of JNJ-81201887 administered in parent clinical studies.
- Phase 2: a mid-size study of how well it works
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 60 and older
You may be able to join if
- Participants who were enrolled and received treatment with JNJ-81201887 or sham in a parent clinical study (81201887MDG2001, 81201887MDG1003)
- Females (women of childbearing potential), male participants, and partners of male participants will not be required to use contraception in this LTE...
- Must sign an informed consent form (ICF) indicating that participant understands the purpose of, and procedures required for, the study and is...
You likely can't join if
- There are no exclusion criteria for this LTE study
The study team makes the final eligibility decision.
Where it's taking place
- Tucson, Arizona, United States
- Fullerton, California, United States
- La Jolla, California, United States
- Oxnard, California, United States
- Pasadena, California, United States
- Poway, California, United States
- Walnut Creek, California, United States
- Fort Lauderdale, Florida, United States
- Gainesville, Florida, United States
- Pensacola, Florida, United States
- St. Petersburg, Florida, United States
- Marietta, Georgia, United States
- Lemont, Illinois, United States
- Carmel, Indiana, United States
- Portland, Maine, United States
- Baltimore, Maryland, United States
- Chevy Chase, Maryland, United States
- Hagerstown, Maryland, United States
- Boston, Massachusetts, United States
- Grand Rapids, Michigan, United States
+ 73 more site(s).
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 60 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Tucson, Arizona, United States; Fullerton, California, United States; La Jolla, California, United States; Oxnard, California, United States; Pasadena, California, United States; Poway, California, United States and 87 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.